Eli Lilly and Company (NYSE: LLY) announced it received a fourth approval from the FDA for ALIMTA (pemetrexed for injection) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE